| 201116-100MG |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C49H63O4P |
|
|
|
| 201116-25MG |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C49H63O4P |
|
|
|
| 201115-1G |
|
NA |
(11aS)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C53H43O4P |
|
|
|
| 201115-100MG |
|
NA |
(11aS)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C53H43O4P |
|
|
|
| 201115-25MG |
|
NA |
(11aS)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C53H43O4P |
|
|
|
| 201114-1G |
|
NA |
(11aR)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C53H43O4P |
|
|
|
| 201114-100MG |
|
NA |
(11aR)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C53H43O4P |
|
|
|
| 201114-25MG |
|
NA |
(11aR)-3,7-Bis[4-?(2-?naphthalenyl)?phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C53H43O4P |
|
|
|
| 201113-1G |
|
NA |
(11aS)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C39H43O4P |
|
|
|
| 201113-100MG |
|
NA |
(11aS)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C39H43O4P |
|
|
|
| 201113-25MG |
|
NA |
(11aS)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C39H43O4P |
|
|
|
| 201112-1G |
|
NA |
(11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C39H43O4P |
|
|
|
| 201112-100MG |
|
NA |
(11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C39H43O4P |
|
|
|
| 201112-25MG |
|
NA |
(11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C39H43O4P |
|
|
|
| 201111-1G |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C51H67O6P |
|
|
|
| 201111-100MG |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C51H67O6P |
|
|
|
| 201111-25MG |
|
NA |
(11aS)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C51H67O6P |
|
|
|
| 201110-1G |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C51H67O6P |
|
|
|
| 201110-100MG |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C51H67O6P |
|
|
|
| 201110-25MG |
|
NA |
(11aR)-3,7-Bis[3,5-bis(tert-butyl)-4-methoxyphenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C51H67O6P |
|
|
|
